Aisha

Home » Archives for Aisha » Page 20
META’s Massive AI Bet: Why Wall Street Hates the Spending, But Smart Money May Be Buying

META’s Massive AI Bet: Why Wall Street Hates the Spending, But Smart Money May Be Buying

Meta Platforms (META) shares experienced volatility following its latest earnings report, not over revenue figures, but due to a massive increase in its AI spending guidance. CEO Mark Zuckerberg’s commitment to building the Artificial Intelligence infrastructure of the future is translating into a sharp rise in Capital Expenditures (CapEx), a move that has deeply unsettled…

Read More
U.S. Firm Serving Major Telcos Confirms Nation-State Hack, Sets Off Alarms

U.S. Firm Serving Major Telcos Confirms Nation-State Hack, Sets Off Alarms

A U.S. company with direct links to global telecom giants has revealed that it suffered a prolonged state-sponsored cyberattack.  Ribbon Communications, based in Texas, provides critical voice and data-routing services to major carriers such as Verizon, Deutsche Telekom and SoftBank Group. Its October 10-Q filing shows that hackers linked to a foreign state gained access…

Read More
X (formerly Twitter) Tests New Link Policy to Re-Engage Journalists

Elon Musk Launches AI-powered Encyclopedia “Grokipedia” to Rival Wikipedia

Elon Musk has introduced Grokipedia, an AI-driven online encyclopedia created by his company xAI. It launched as version 0.1 with approximately 885,000 articles.  Musk positioned Grokipedia as a rival to Wikipedia, which he has publicly criticised for having a left-leaning bias. He said the new platform is committed to delivering “the full truth”.  Unlike Wikipedia,…

Read More
Merck launches $3 billion drug-factory in Virginia to boost U.S. manufacturing.

Merck and Eisai End Liver Cancer Drug Trial After Disappointing Results

Merck and Eisai have stopped a major late-stage trial for their liver cancer treatment after early results showed the drug combination was unlikely to improve patient survival. The two companies were testing Keytruda, Merck’s top immunotherapy drug, with Eisai’s cancer medicine Lenvima. The goal was to see whether the combination could help patients with hepatocellular…

Read More